Carolyne Hathaway

Latham & Watkins LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Unapproved New Uses: FDA Revisits Policies on Distributing Scientific Publications

In new Draft Guidance, FDA revises requirements for manufacturers’ distribution of publications about off-label uses for approved drugs or devices. On March 3, 2014, the Food and Drug Administration (FDA) released a...more

3/18/2014 - Drug Manufacturers FDA Off-Label Use Pharmaceutical Prescription Drugs

A Look at the FDA’s New Social Media Guidance

Draft guidance provides the medical industry with long-awaited boundaries for marketing in the electronic age. On January 13, 2014, the Food and Drug Administration (FDA) released a draft guidance document providing...more

2/14/2014 - Advertising Drug Manufacturers FDA Social Media

FDA’s Final Guidance Distinguishes Liquid Dietary Supplements from Beverages

Two new FDA guidance documents can assist both conventional beverage and liquid dietary supplement manufacturers to avoid costly mischaracterization and enforcement action. The US Food and Drug Administration (FDA or...more

2/6/2014 - Dietary Supplements FDA Food Labeling

The Regulation of Follow-on Biologics

What is new in the world of follow-on biologics? Manthei: Congress enacted the Biologics Price Competition and Innovation Act of 2009 to provide an alternative to the submission of a Biologics License Application for...more

12/10/2013 - Biologics FDA Life Sciences Patents Pharmaceutical Prescription Drugs

Preparing for a "New Era of Medical Product Development"

FDA report demonstrates support for personalized medicine and more efficient regulatory pathways. In a new report issued by the Food and Drug Administration (FDA) on October 28, 2013, Commissioner of Food and Drugs...more

11/8/2013 - FDA Medical Devices Personalized Medicine

5 Results
|
View per page
Page: of 1